Literature DB >> 25857717

A novel modeling framework for ordinal data defined by collapsed counts.

James S McGinley1, Patrick J Curran2, Donald Hedeker3.   

Abstract

Adolescent alcohol use is a serious public health concern. Despite advances in the theoretical conceptualization of pathways to alcohol use, researchers are limited by the statistical techniques currently available. Researchers often fit linear models and restrictive categorical models (e.g., proportional odds models) to ordinal data with many response categories defined by collapsed count data (0 drinking days, 1-2 days, 3-6 days, etc.). Consequently, existing models ignore the underlying count process, resulting in disjoint between the construct of interest and the models being fitted. Our proposed ordinal modeling approach overcomes this limitation by explicitly linking ordinal responses to a suitable underlying count distribution. In doing so, researchers can use maximum likelihood estimation to fit count models to ordinal data as if they had directly observed the underlying discrete counts. The usefulness of our ordinal negative binomial and ordinal zero-inflated negative binomial models is verified by simulation studies. We also demonstrate our approach using real empirical data from the 2010 National Survey of Drug Use and Health. Results show the benefit of the proposed ordinal modeling framework compared with existing methods.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  collapsed counts; count data; grouped counts; ordinal data; ordinal-count; zero inflation

Mesh:

Year:  2015        PMID: 25857717     DOI: 10.1002/sim.6495

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation.

Authors:  Megan Kirouac; Eric Kruger; Adam D Wilson; Kevin A Hallgren; Katie Witkiewitz
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.